A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
Elmer Yu, Karen Miotto, Evaristo Akerele, Ann Montgomery, Ahmed Elkashef, Robert Walsh, Ivan Montoya, Marian W. Fischman, Joseph Collins, Frances McSherry, Kathy Boardman, David K. Davies, Charles P.Том:
97
Рік:
2008
Мова:
english
Сторінки:
169
DOI:
10.1016/j.drugalcdep.2008.04.002
Файл:
PDF, 656 KB
english, 2008